NexPoint Diversified Real Estate Trust (NXDT) Completes Transition to a Diversified REIT

DALLAS, July 5, 2022  — NexPoint Diversified Real Estate Trust (NYSE: NXDT) (the “Company”) announced that the Securities and Exchange Commission (“SEC”) issued an order, effective July 1, 2022, enabling the Company to complete the transition of its business to a diversified real estate investment trust (“REIT”).1 The Company’s common and preferred shares will continue to be traded […]

NexPoint Leads Series B Financing for Biotechnology Company Sapience Therapeutics

HARRISON, N.Y., May 31, 2022 /PRNewswire/ — Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address difficult-to-treat cancers, announced today the completion of a $41 million Series B financing. The financing was led by new investor NexPoint and included participation from existing investors Bristol Myers Squibb, Eshelman […]

NexPoint Advisors, HomeSource Launch SFR Initiative

“Multibillion-dollar alternative investment platform NexPoint Advisors L.P., has partnered with HomeSource Operations LLC, in the formation of a new NexPoint advised real estate investment trust (REIT). The REIT will be used to acquire, build and operate single-family rental homes. It will target existing SFR properties and new construction build-to-rent (BTR) homes in high-growth markets.” Click here to read […]

NexPoint Announces New Single-Family Rental Initiative

Initiative Will Focus on Acquisitions of Existing Single-Family Rental Homes and Opportunities with Build-to-Rent Communities DALLAS, May 19, 2022 /PRNewswire/ — NexPoint Advisors, L.P. (“NexPoint”), a multibillion-dollar alternative investment platform, today announced the formation of a new NexPoint advised real estate investment trust (“REIT”). NexPoint is partnering with HomeSource Operations, LLC to acquire, build, and operate single-family […]

NexPoint Participates in Series C Financing for Apnimed, a Clinical-stage Pharmaceutical Company Focused on Treating Sleep Disorders

CAMBRIDGE, Mass. May 4, 2022 – Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, announced today that it has raised $62.5 million of committed capital in a Series C financing. New investor, Sectoral Asset Management, led the round. Also participating were new investors […]

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution

DALLAS – May 2, 2022 – NexPoint Diversified Real Estate Trust (NYSE: NXDT) (“NXDT” or the “Company”) today announced its regular monthly distribution on its common stock of $0.05 per share. The distribution will be payable on May 31, 2022 to shareholders of record at the close of business May 24, 2022. About the NexPoint […]

NexPoint Diversified Real Estate Trust Declares Regular Monthly Distribution

DALLAS – April 1, 2022 – NexPoint Diversified Real Estate Trust (NYSE: NXDT) (“NXDT” or the “Company”) today announced its regular monthly distribution on its common stock of $0.05 per share. The distribution will be payable on April 29, 2022 to shareholders of record at the close of business April 22, 2022. About the NexPoint […]

Contact Us